Prenatal diagnosis and molecular cytogenetic characterization of mosaicism for a small supernumerary marker chromosome derived from ring chromosome 4. 2011

Chih-Ping Chen, and Ming Chen, and Yi-Ning Su, and Fuu-Jen Tsai, and Schu-Rern Chern, and Pei-Chen Wu, and Wen-Lin Chen, and Li-Feng Chen, and Chen-Wen Pan, and Wayseen Wang
Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan. cpc_mmh@yahoo.com

OBJECTIVE To present prenatal diagnosis and molecular cytogenetic characterization of mosaicism for a small supernumerary marker chromosome (sSMC) derived from ring chromosome, or r(4) by spectral karyotyping (SKY), fluorescence in situ hybridization (FISH), and array comparative genomic hybridization (aCGH). RESULTS A 37-year-old, primigravid woman underwent amniocentesis at 18 weeks of gestation because of advanced maternal age. Amniocentesis revealed a de novo ring-shaped sSMC in 16 of 31 amniocyte colonies. The parental karyotypes were normal. Level II ultrasound findings were unremarkable. Repeated amniocentesis revealed a karyotype of 47,XX,+mar[17]/46,XX[19]. The sSMC was characterized by SKY and FISH, which showed a chromosome 4 origin of the sSMC. aCGH demonstrated a 21.7-Mb gain in the gene dosage encompassing the region of 4p12→q13.2. The sSMC was r(4)(p12q13.2). The fetal karyotype was 47,XX,+r(4)(p12q13.2)[17]/46,XX[19]. The pregnancy was subsequently terminated. The fetus postnatally manifested hypertelorism, epicanthic folds, a prominent nose, a triangular face, low-set ears, clinodactyly of the fingers, and small big toes. Postnatal cytogenetic analyses of fetal and extraembryonic tissues revealed the karyotypes of 47,XX,+r(4)[18]/46,XX[21] in cord blood, 47,XX,+r(4)[20]/48,XX,+r(4),+r(4)[1]/46,XX[9] in umbilical cord, 47,XX,+r(4)[14]/47,XX,+dic r(4)[1]/46,XX[25] in skin, 47,XX,+r(4)[15]/46,XX[25] in amnion, and 47,XX,+r(4)[12]/47,XX,+dic r(4)[1]/46,XX[2] in placenta. CONCLUSIONS SKY, FISH, and aCGH are helpful in genetic counseling of prenatally detected sSMCs by providing the immediate and thorough information on the origin and genetic component of the sSMC.

UI MeSH Term Description Entries
D009030 Mosaicism The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from a single ZYGOTE, as opposed to CHIMERISM in which the different cell populations are derived from more than one zygote.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D002894 Chromosomes, Human, Pair 4 A specific pair of GROUP B CHROMOSOMES of the human chromosome classification. Chromosome 4
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000015 Abnormalities, Multiple Congenital abnormalities that affect more than one organ or body structure. Multiple Abnormalities
D000028 Abortion, Induced Intentional removal of a fetus from the uterus by any of a number of techniques. (POPLINE, 1978) Embryotomy,Abortion (Induced),Abortion Failure,Abortion History,Abortion Rate,Abortion Technics,Abortion Techniques,Abortion, Drug-Induced,Abortion, Rivanol,Abortion, Saline-Solution,Abortion, Soap-Solution,Anti-Abortion Groups,Fertility Control, Postconception,Induced Abortion,Previous Abortion,Abortion Failures,Abortion Histories,Abortion Rates,Abortion Technic,Abortion Technique,Abortion, Drug Induced,Abortion, Previous,Abortion, Saline Solution,Abortion, Soap Solution,Abortions (Induced),Abortions, Drug-Induced,Abortions, Induced,Abortions, Previous,Abortions, Rivanol,Abortions, Saline-Solution,Abortions, Soap-Solution,Anti Abortion Groups,Anti-Abortion Group,Drug-Induced Abortion,Drug-Induced Abortions,Embryotomies,Failure, Abortion,Failures, Abortion,Group, Anti-Abortion,Groups, Anti-Abortion,Histories, Abortion,History, Abortion,Induced Abortions,Postconception Fertility Control,Previous Abortions,Rate, Abortion,Rates, Abortion,Rivanol Abortion,Rivanol Abortions,Saline-Solution Abortion,Saline-Solution Abortions,Soap-Solution Abortion,Soap-Solution Abortions,Technic, Abortion,Technics, Abortion,Technique, Abortion,Techniques, Abortion
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Chih-Ping Chen, and Ming Chen, and Yi-Ning Su, and Fuu-Jen Tsai, and Schu-Rern Chern, and Pei-Chen Wu, and Wen-Lin Chen, and Li-Feng Chen, and Chen-Wen Pan, and Wayseen Wang
February 2009, American journal of medical genetics. Part A,
Chih-Ping Chen, and Ming Chen, and Yi-Ning Su, and Fuu-Jen Tsai, and Schu-Rern Chern, and Pei-Chen Wu, and Wen-Lin Chen, and Li-Feng Chen, and Chen-Wen Pan, and Wayseen Wang
July 2012, American journal of medical genetics. Part A,
Chih-Ping Chen, and Ming Chen, and Yi-Ning Su, and Fuu-Jen Tsai, and Schu-Rern Chern, and Pei-Chen Wu, and Wen-Lin Chen, and Li-Feng Chen, and Chen-Wen Pan, and Wayseen Wang
March 2020, Taiwanese journal of obstetrics & gynecology,
Chih-Ping Chen, and Ming Chen, and Yi-Ning Su, and Fuu-Jen Tsai, and Schu-Rern Chern, and Pei-Chen Wu, and Wen-Lin Chen, and Li-Feng Chen, and Chen-Wen Pan, and Wayseen Wang
July 2005, American journal of medical genetics. Part A,
Chih-Ping Chen, and Ming Chen, and Yi-Ning Su, and Fuu-Jen Tsai, and Schu-Rern Chern, and Pei-Chen Wu, and Wen-Lin Chen, and Li-Feng Chen, and Chen-Wen Pan, and Wayseen Wang
September 2023, Molecular cytogenetics,
Chih-Ping Chen, and Ming Chen, and Yi-Ning Su, and Fuu-Jen Tsai, and Schu-Rern Chern, and Pei-Chen Wu, and Wen-Lin Chen, and Li-Feng Chen, and Chen-Wen Pan, and Wayseen Wang
November 1999, American journal of medical genetics,
Chih-Ping Chen, and Ming Chen, and Yi-Ning Su, and Fuu-Jen Tsai, and Schu-Rern Chern, and Pei-Chen Wu, and Wen-Lin Chen, and Li-Feng Chen, and Chen-Wen Pan, and Wayseen Wang
July 2019, Medicine,
Chih-Ping Chen, and Ming Chen, and Yi-Ning Su, and Fuu-Jen Tsai, and Schu-Rern Chern, and Pei-Chen Wu, and Wen-Lin Chen, and Li-Feng Chen, and Chen-Wen Pan, and Wayseen Wang
November 2020, Taiwanese journal of obstetrics & gynecology,
Chih-Ping Chen, and Ming Chen, and Yi-Ning Su, and Fuu-Jen Tsai, and Schu-Rern Chern, and Pei-Chen Wu, and Wen-Lin Chen, and Li-Feng Chen, and Chen-Wen Pan, and Wayseen Wang
January 2003, Cytogenetic and genome research,
Chih-Ping Chen, and Ming Chen, and Yi-Ning Su, and Fuu-Jen Tsai, and Schu-Rern Chern, and Pei-Chen Wu, and Wen-Lin Chen, and Li-Feng Chen, and Chen-Wen Pan, and Wayseen Wang
January 2014, Molecular cytogenetics,
Copied contents to your clipboard!